EPO and hypertrophic cardiomyopathy: ΔEPORE mice also showed an increased systolic volume and systolic diameter compared to WT male mice, suggesting that in WT mice, endogenous EPO in non-hematopoietic tissues might play a role in protecting against hypertrophic cardiomyopathy (Figures 1H, I).